NOS3 and metabolic dysfunction-associated steatotic liver disease: Remarkably, many human chronic diseases, like insulin resistance, type 2 diabetes, and obesity are associated with a deficiency in the eNOS−/− expression and/or function,23, 63 highlighting the role of NO in the pathophysiology of NAFLD.